China Pet Veterinary Drug Approval Timeline — MOA Announcements No. 1022 through 1040 (Jan–Jul 2026)
This topic provides a consolidated timeline of pet-specific or pet-relevant new veterinary drug approvals (新兽药) published by China's Ministry of Agriculture and Rural Affairs (农业农村部, MOA) across consecutive announcements from Announcement No. 1022 through No. 1040, spanning January to July 2026.
All new veterinary drug registrations listed below were approved under the *Regulations on the Administration of Veterinary Drugs* (《兽药管理条例》) and the *Measures for the Registration of Veterinary Drugs* (《兽药注册办法》), effective from their respective promulgation dates.
Timeline of Pet-Specific New Drugs (2026)
Announcement No. 1022 — 2026年5月14日 (May 14, 2026)
New veterinary drug registration certificate range (新兽药注册证书号范围): （2026）新兽药证字 50–55号
| Cert No. | Drug name | Class | Monitoring period | Note |
|---|---|---|---|---|
| 50 | Fluolaner (氟雷拉纳) | Category 2 (二类) | 4 years (4年) | Ectoparasiticide active ingredient (抗寄生虫活性成分) |
| 51 | Fluolaner Drops (氟雷拉纳滴剂) | Category 2 (二类) | 4 years (4年) | Pet topical ectoparasiticide drops (宠物用外用抗寄生虫滴剂) |
| 52 | Dangshen Shengmai Mixture (党参生脉合剂) | Category 3 (三类) | 3 years (3年) | Contains pet-pharma research units (含 pet pharma 研制单位) |
| 53 | Fowl Adenovirus Egg-Yolk Antibody (禽腺病毒卵黄抗体) | Category 3 (三类) | 3 years (3年) | — |
| 54 | Fusidic Acid Ophthalmic Solution (夫西地酸滴眼液) | Category 5 (五类) | 3 years (3年) | Pet ophthalmic drug (宠物用眼药) |
| 55 | Pregabalin Oral Solution (普瑞巴林内服溶液) | Category 5 (五类) | 3 years (3年) | Pet analgesic, subject to prescription management (宠物用镇痛，纳入兽用处方药) |
Source: MOA Announcement No. 1022 (农业农村部公告第1022号), 2026年5月14日 — ivdc-202605-t20260518_62268.html
---
Announcement No. 1026 — 2026年6月4日 (June 4, 2026)
New veterinary drug registration certificate range (新兽药注册证书号范围): （2026）新兽药证字 56–65号
| Cert No. | Drug name | Class | Monitoring period | Note |
|---|---|---|---|---|
| 56 | Gralen (格拉匹仑) | Category 2 (二类) | 4 years (4年) | Active ingredient (活性成分) |
| 57 | Gralen Tablets (格拉匹仑片) | Category 2 (二类) | 4 years (4年) | Canine osteoarthritis analgesia, pet-use (犬用骨关节炎镇痛，宠物用) |
| 58 | Fowl Adenovirus Egg-Yolk Antibody (禽腺病毒卵黄抗体) | Category 3 (三类) | 3 years (3年) | — |
| 59 | Canine Distemper Virus Antiserum (犬瘟热病毒抗血清) | Category 3 (三类) | 3 years (3年) | Pet-use (宠物用) |
| 60 | Newcastle Disease, Egg-Drop Syndrome Combined Inactivated Vaccine (鸡新城疫、减蛋综合征三联灭活疫苗) | Category 3 (三类) | 3 years (3年) | — |
| 61 | Pseudorabies Live Vaccine (猪伪狂犬病活疫苗) | Category 3 (三类) | 3 years (3年) | — |
| 62 | Mink Distemper Live Vaccine (HL001-M3 Strain) (水貂犬瘟热活疫苗（HL001-M3株）) | Category 3 (三类) | 3 years (3年) | Pet/specialty-animal use (宠物/特种养殖用) |
| 63 | Porcine Circovirus + Mycoplasma Hyopneumoniae Combined Inactivated Vaccine (猪圆环+肺炎支原体二联灭活疫苗) | Category 3 (三类) | 3 years (3年) | — |
| 64 | Chicken Bursin Injection (鸡法氏囊素注射液) | Category 3 (三类) | 3 years (3年) | — |
| 65 | Itraconazole Ointment (伊曲康唑软膏) | Category 4 (四类) | 3 years (3年) | Pet antifungal (宠物用抗真菌) |
Source: MOA Announcement No. 1026 (农业农村部公告第1026号), 2026年6月4日 — ivdc-202606-t20260605_63436.html
---
Announcement No. 1038 — 2026年7月6日 (July 6, 2026)
New veterinary drug registration certificate range (新兽药注册证书号范围): （2026）新兽药证字 66–71号
| Cert No. | Drug name | Class | Monitoring period | Note |
|---|---|---|---|---|
| 66 | Chlorhexidine Acetate Solution (醋酸氯己定溶液) | Category 3 (三类) | 3 years (3年) | Pet topical drug, for dog skin/wound/mucous-membrane disinfection (宠物用外用药，用于犬皮肤/创面/黏膜消毒) |
| 67 | Huangsang Qingfei San (黄桑清肺散) | Category 3 (三类) | 3 years (3年) | — |
| 68 | Porcine Circovirus Type 2 Baculovirus-Vector Inactivated Vaccine (SL08 Strain) (猪圆环病毒2型杆状病毒载体灭活疫苗（SL08株）) | Category 3 (三类) | 3 years (3年) | — |
| 69 | Poultry Quadrivalent Inactivated Vaccine (鸡四联灭活疫苗) | Category 3 (三类) | 3 years (3年) | — |
| 70 | Feline Rhinotracheitis + Calicivirus + Panleukopenia Combined Inactivated Vaccine (WX+SH14+0918 Strains) (猫鼻气管炎+猫杯状病毒+猫泛白细胞减少症三联灭活疫苗（WX株+SH14株+0918株）) | Category 3 (三类) | 3 years (3年) | Pet cat vaccine (宠物用猫疫苗) |
| 71 | Gabapentin Oral Solution (加巴喷丁内服溶液) | Category 4 (四类) | 3 years (3年) | Pet analgesic, subject to prescription management (宠物用镇痛，纳入兽用处方药) |
Source: MOA Announcement No. 1038 (农业农村部公告第1038号), 2026年7月6日 — ivdc-announcement-1038-20260707.html
---
Cross-Cutting Observations
- Pet new-veterinary-drug certificate numbers now cover 50–71号 (2026 annual series), representing a significant expansion of the domestic pet pharmaceutical catalogue.
- Cat vaccine (猫用疫苗): Announcement 1038 introduces the first feline triple inactivated vaccine (猫三联灭活疫苗) covering FVR, FCV and FPL in a single injection (certificate 证字70号), a notable milestone for domestic cat health products.
- Companion-animal analgesics/neuro drugs (宠物用镇痛/神经用药): Gabapentin (加巴喷丁, 证字71号) and Pregabalin (普瑞巴林, 证字55号) represent the first formally registered companion-animal neurology/pain-management drugs in China.
- Ectoparasiticide (抗寄生虫): Fluolaner (氟雷拉纳, 证字50–51号) is an isoxazoline-class compound registered as a novel pet ectoparasiticide.
- Osteoarthritis (骨关节炎): Gralen Tablets (格拉匹仑片, 证字57号) is the first registered canine osteoarthritis pain-management drug in China.
---
Source: Compiled from ivdc-202605-t20260518_62268.html · ivdc-202606-t20260605_63436.html · ivdc-announcement-1038-20260707.html · ivdc-announcement-1040-20260713.html